glp-1 gip therapy alternatives after discontinuation and in Type 1 Diabetes Therapy: A Time for Reappraisal? Causes and consequences of discontinuation
Description
How many people take GLP-1 medications
DPP-4 inhibitors were introduced for the treatment of type 2 diabetes in 2006
Not for use during pregnancy or nursing without guidance from your provider
Guidelines currently recommend organ-specific management of obesity-related complications
In the last 20 years, the emergence of pharmacological treatments for obesity based on gastrointestinal hormones has transformed the ...
Some people who take GLP-1 drugs such as semaglutide and tirzepatide see little to no changes to their weight
